1.Expression of c-erbB-2 and Distribution of S-100 Protein Positive Dendritic Cells in Squamous Cell Carcinoma of the Uterine Cervix.
Jeong Ok SHIN ; Seung Do CHOI ; Jae Gun SUNWOO ; Dong Han BAE ; Dae Jung KIM
Korean Journal of Gynecologic Oncology and Colposcopy 2000;11(4):397-403
OBJECTIVE: The aim of this study was to assess the relationship between disease progression and expression of c-erbB-2 and S-100 protein positive dendritic cells in Cervical cancer. STUDY DESIGN: Tissues were analyzed from 100 patients. Each of them had invasive carcinoma(44), microinvasive(12), CIS(33), CIN(II) before treatment, c-erbB-2 oncoprotein expression and S-100 protein positive dendritic cell were confirmed by immunohistochemical staining. (Avidin-biotin complex method) RESULTS: C-erbB-2 immunostaining was significantly associated with disease progression (p<0.05). In case of CIN I, there was not noted stained specimen but in case of invasive carcinoma, 24 cases of stained specimen were noted. S-100 protein positive dendritic cell was not associated with disease progression of cervical carcinoma.(p>0.05) CONCLUSIONS: According to our results, c-erbB-2 is possible factor in Carcinogenesis of cervical carcinoma with progression of it. and S-100 protein positive dendritic cell was not associated with disease progression of cervical carcinoma.
Carcinogenesis
;
Carcinoma, Squamous Cell*
;
Cervix Uteri*
;
Dendritic Cells*
;
Disease Progression
;
Female
;
Humans
;
S100 Proteins*
;
Uterine Cervical Neoplasms
2.Development of Test System for Detection of Antibody to Human Immunodeficiency Virus Type 1 Subtype O.
Young Shik CHO ; Gun Woo HA ; Sunyoung KIM ; Seung Shin YU ; Sang Gook LEE ; Myung Hwan CHO ; Hyung Sik SHIN
Journal of the Korean Society of Virology 1998;28(1):31-38
In Korea, all domestic made test systems for detecting antibodies in HIV-1 contain the antigens from human immunodeficiency type 1 (HIV-1) subtype B. However, because HIV-1 subtype O is significantly different in amino acid sequences from all other subtypes of HIV-1, there has been a need for developing a test for detecting antibodies in subtype O. For this purpose, the entire nucleotide sequence corresponding to the extracellular domain of the transmembrane glycoprotein of HIV-1 subtype O was synthesized with consideration of Escherichia coli cordon usage. Various regions of the extracellular domain were cloned into E. coli expression vectors and tested for levels of protein production. The nucleotide sequence, named ECTM, that can encode a 129 amino acid-long peptide, was found to be expressed at a high level in E. coli. The protein of approximately 17 kDa specifically reacted with sera from individuals infected with HIV-1 subtype O. The ECTM protein was purified to near homogeneity by the CM-T gel chromatography, using concentrated, denatured inclusion bodies. In Western blot analysis, the purified viral antigen reacted with sera from individuals infected with subtype O more efficiently than subtype B. The enzyme linked immunoabsorbent assay (ELISA) system was developed using the subtype O viral protein and compared with the commercially available kit lacking the antigens from subtype O. The ELISA kit containing the subtype O antigen ECTM alone efficiently reacted with sera from individuals infected with subtype O. The subtype O antigen-containing kit produced a positive absorbence even when sera were diluted 512-fold, suggesting a high sensitivity. The commercially available kit also reacted with subtype O sera, but produced a negative result at a dilution of 8-fold. Our results suggest that the currently available kit may not be able to efficiently detect subtype O sera and that the viral protein developed in this study may be added to the current system to maximize the detection of sera from individuals infected with subtype O.
Amino Acid Sequence
;
Antibodies
;
Base Sequence
;
Blotting, Western
;
Chromatography, Gel
;
Clone Cells
;
Enzyme-Linked Immunosorbent Assay
;
Escherichia coli
;
Glycoproteins
;
HIV*
;
HIV-1*
;
Humans*
;
Inclusion Bodies
;
Korea
;
O Antigens
3.Changes of Corticotropin-Releasing Factor(CRF) and Neuropeptide Y(NPY) of Rats in Response to Footshock or Reexposure to Conditions Previously Paired with Footshock.
Kyung Ho SHIN ; Sung Jin KIM ; Kuem Ju LEE ; Seung Gun SHIN ; You Chan SHIN ; Min Soo LEE
Journal of the Korean Society of Biological Psychiatry 2003;10(1):62-69
Corticotropin-releasing factor(CRF) and neuropeptide Y(NPY) are known to play important roles in mediating stress responses and stress-related behavior. To elucidate the role of neuropeptides in response to the condition that had paired with traumatic event, we observed the changes of CRF and NPY by immunohistochemistry using a conditioned footshock paradigm. Male Sprague-Dawley rats were placed in a shuttle box and exposed to 20 pairings of a tone(< 70dB, 5sec) followed by a footshock(FS, 0.8mA, 1sec) over 60min. A second group was exposed to the tone-footshock pairings, returned to the homecage for 2days, and then reexposed to the test chamber and 20tones alone for 60min, prior to sacrifice. Control groups were : a) sacrificed without exposure to FS ; b) exposed to the tone-footshock pairings and then sacrificed two days later ; or c) exposed to the chamber and tones alone, returned to the homecage for 2days and then reexposed to the chamber and 20tones over 60min prior to sacrifice. CRF was increased in animals exposed to FS or the aversive condition(context and tone) that had paired to FS in bed nucleus of the stria terminalis (BNST) compared to the control. NPY was increased by FS in amygdala and PVN, but the condition previously associated with FS results in slight increase only in amygdala area. These results suggest that the BNST appears to be the mostly involved neural circuit in response to explicit cues previously paired with footshock. Moreover, this study raise the possibility that increased CRF peptide in the BNST in response to re-exposure to the aversive condition may underlie, in part, the experience of conditioned fear-related anxiety behavior.
Amygdala
;
Animals
;
Anxiety
;
Cues
;
Humans
;
Immunohistochemistry
;
Male
;
Negotiating
;
Neuropeptides*
;
Rats*
;
Rats, Sprague-Dawley
4.Changes in lymphocyte subsets following open-heart surgery; a study for changes in lymphocyte subsets.
Jae Joon HWANG ; Jae Seung SHIN ; Gun LEE ; Hyung Joo PARK ; Young Ho CHOI ; Hark Jei KIM ; Hyoung Mook KIM
The Korean Journal of Thoracic and Cardiovascular Surgery 1992;25(11):1185-1191
No abstract available.
Lymphocyte Subsets*
;
Lymphocytes*
5.The clinical analysis of 32 cases of coronary artery bypass graft.
Hark Jei KIM ; Gun LEE ; Jae Jun WHANG ; Jae Seung SHIN ; Hyoung Ju PARK ; Young Ho CHOI ; Hyoung Mook KIM
The Korean Journal of Thoracic and Cardiovascular Surgery 1992;25(11):1369-1375
No abstract available.
Coronary Artery Bypass*
;
Coronary Vessels*
6.Supernumerary Tooth in Nasal Cavity: Report of 1 Case.
Gun Soo LEE ; Geon Young LEE ; Seung Leul HONG ; Jung Guk SHIN
Korean Journal of Otolaryngology - Head and Neck Surgery 1998;41(7):949-951
Supernumerary tooth, named mesodens, occur between the maxillary central incisors are generally found in pairs, although it is sometimes found singly. An inverted mesiodens may move toward the nasal cavity and erupt in the floor of the nose. Approximately 90% of all supernumerary tooth usually appear in the area of the maxilla, where they disrupt the position and eruption of normal teeth. A supernumerary tooth may closely resemble the teeth of the group to which it belongs, i.e., molars, premolars or anterior teeth.
Bicuspid
;
Incisor
;
Maxilla
;
Molar
;
Nasal Cavity*
;
Nose
;
Tooth
;
Tooth, Supernumerary*